What is Shandong Xinhua Pharmaceutical Co Operating Cash Flow per Share?
Shandong Xinhua Pharmaceutical Co's operating cash flow per share for the
three
months ended in Mar. 2024 was HK$0.06.
Shandong Xinhua Pharmaceutical Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was HK$0.77.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Shandong Xinhua Pharmaceutical Co was -18.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -17.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 0.40% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 4.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Shandong Xinhua Pharmaceutical Co's Operating Cash Flow per Share or its related term are showing as below:
HKSE:00719'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -52.6 Med: -0.5 Max: 112
Current: -17
During the past 13 years, Shandong Xinhua Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 112.00% per year. The lowest was -52.60% per year. And the median was -0.50% per year.
HKSE:00719's 3-Year OCF Growth Rate is ranked worse than 78.26% of 805
companies
in the Drug Manufacturers industry
Industry Median: 7.5
vs HKSE:00719: -17.00
Shandong Xinhua Pharmaceutical Co Operating Cash Flow per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shandong Xinhua Pharmaceutical Co Operating Cash Flow per Share Chart
Competitive Comparison of Shandong Xinhua Pharmaceutical Co's Operating Cash Flow per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Xinhua Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Xinhua Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shandong Xinhua Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Shandong Xinhua Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.
Shandong Xinhua Pharmaceutical Co Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.77
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Xinhua Pharmaceutical Co Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Shandong Xinhua Pharmaceutical Co (HKSE:00719) Business Description
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.
Shandong Xinhua Pharmaceutical Co (HKSE:00719) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00719 has been successfully added to your 